Dentalcorp Reports First Quarter 2025 Results

TORONTO--(BUSINESS WIRE)--dentalcorp Holdings Ltd. ('Dentalcorp' or the 'Company') (TSX: DNTL), Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the first quarter ended March 31, 2025, reaffirmed the full year 2025 guidance previously provided in the Company's news release dated March 21, 2025, and announced its outlook for the second quarter of 2025. All financial figures are in Canadian dollars unless otherwise indicated.
'Our teams across the country delivered another quarter of strong results, with revenue and Adjusted EBITDA growth of approximately 10% and 11%, respectively, over the first quarter of 2024, and setting new highs for both metrics. We continued to realize operating leverage across the business, with first quarter Adjusted EBITDA Margin expanding 20 basis points over the first quarter of 2024 to 18.5%, marking our fourth consecutive quarter of year-over-year Adjusted EBITDA Margin expansion,' said Graham Rosenberg, CEO and Chairman of Dentalcorp.
'We generated a record $44.3 million in Adjusted Free Cash Flow in the first quarter of 2025, representing an increase of approximately 26% over the first quarter of 2024,' Rosenberg continued. 'This led to continued deleveraging, with our Net Debt / PF Adjusted EBITDA after rent Ratio decreasing to 3.77x, a reduction of 0.57x from the first quarter of 2024, marking our sixth consecutive quarter of deleveraging,' Rosenberg said.
'Following a strong first quarter of 2025 that exceeded expectations, we're carrying this momentum into the second quarter, anticipating SPRG of 3.0% to 5.0%, revenue growth of 9.0% to 10.0%, and Adjusted EBITDA Margin expansion of 20 basis points over the second quarter of 2024, to 18.7%,' Nate Tchaplia, President and Chief Financial Officer said.
'During the first quarter of 2025, we acquired 12 new practices that are expected to generate $8.3 million in PF Adjusted EBITDA after rent, at an average multiple of 7.4x, and as of today, have closed on or signed LOIs for acquisitions representing 70% of our annual target,' Tchaplia continued.
'With regards to the federal government's Canadian Dental Care Plan ('CDCP'), we have treated over 95,000 CDCP patients with 95% of our practices currently accepting CDCP patients. During the first quarter of 2025, the federal government announced that the 18-64 age cohort will be eligible to receive treatment under the program as of June 1, 2025. This announcement led to some visit deferrals in the quarter and we expect this to continue until these new eligible patients can begin their treatment,' Tchaplia concluded.
'We are reaffirming our full year 2025 guidance, where we expect to see SPRG of 3.0% to 5.0%, an accelerated pace of M&A with acquisitions representing $25 million+ of PF Adjusted EBITDA after rent, Pre-tax Adjusted Free Cash flow per Share growth of 15%+, and another year of Adjusted EBITDA Margin expansion of 20+ basis points,' said Rosenberg.
Other Metrics
Adjusted EBITDA (a)
75.9
68.1
Adjusted net income (a)
20.7
24.7
Adjusted free cash flow (a)
44.3
35.2
Expand
(a)
Non-IFRS financial measure, non-IFRS ratio or supplementary financial measure. See the 'Non-IFRS and Other Financial Measures and Ratios' section of this release for definitions and quantitative reconciliations.
Expand
Conference Call Notification
The Company will hold a conference call to provide a business update on Monday, May 12, 2025, at 8:30 a.m. ET. A question-and-answer session will follow the business update.
Non-IFRS and Other Financial Measures and Ratios
As appropriate, we supplement our results of operations determined in accordance with IFRS with certain non-IFRS and other financial measures and ratios that we believe these non-IFRS and other financial measures are useful to investors, lenders and others in assessing our performance and highlighting trends in our core business that may not otherwise be apparent when relying solely on IFRS measures. Our management also uses non-IFRS measures for purposes of comparing to prior periods; preparing annual operating budgets; developing future projections and earnings growth prospects; measuring the profitability of ongoing operations; analyzing our financial condition, business performance and trends, including the operating performance of the business after taking into consideration the acquisitions of dental practices; and determining components of employee compensation. As such, these measures are provided as additional information to complement IFRS measures by providing further understanding of our results of operations from management's perspective, including how we evaluate our financial performance and how we manage our capital structure. We also believe that securities analysts, investors and other interested parties frequently use these non-IFRS and other financial measures and industry metrics in the evaluation of issuers. These non-IFRS and other financial measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS, may include or exclude certain items as compared to similar IFRS measures and may not be comparable to similarly-titled measures reported by other companies. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of our financial information reported under IFRS. For further information on non-IFRS and other financial measures and ratios, including the most directly comparable IFRS measures, composition of the measures, a description of how we use these measures, an explanation of how these measures are useful to investors and applicable reconciliations, refer to the 'Non-IFRS and Other Financial Measures', 'Non-IFRS Financial Measures', 'Non-IFRS Ratios' and 'Certain Supplementary Financial Measures' sections of management's discussion and analysis of operations for the three months and year ended March 31, 2025, which is available on the Company's profile on SEDAR+ at www.sedarplus.ca.
EBITDA
'EBITDA' means, for the applicable period, net loss and comprehensive loss plus (a) net finance costs, (b) income tax expense (recovery), and (c) depreciation and amortization. Management does not use EBITDA as a financial performance metric, but we present EBITDA to assist investors in understanding the mathematical development of Adjusted EBITDA and Same Practice EBITDA Growth. The most comparable IFRS measure to EBITDA is Net loss and comprehensive loss, for which a reconciliation is provided below.
Adjusted EBITDA
'Adjusted EBITDA' is calculated by adding to EBITDA certain expenses, costs, charges or benefits incurred in such period which in management's view are either not indicative of underlying business performance or impact the ability to assess the operating performance of our business, including: (a) net impact of unrealized foreign exchange gains or losses on non-cash balances; (b) share-based compensation; (c) external acquisition expenses; (d) change in fair value of financial instruments at fair value through profit or loss; (e) other corporate costs; (f) loss on disposal of dental practices; (g) loss on disposal and impairment of property and equipment and intangible assets; (h) loss on settlement of other receivables; (i) impairment of right-of-use assets; (j) post-employment benefits; and (k) short-term benefits. Adjusted EBITDA is a supplemental measure used by management and other users of our financial statements to assess the financial performance of our business without regard to the effects of interest, depreciation and amortization costs, expenses that are not considered reflective of underlying business performance, and other expenses that are expected to be one-time or non-recurring. We use Adjusted EBITDA to facilitate a comparison of our operating performance on a consistent basis from period to period and to provide for a more complete understanding of factors and trends affecting our business. The most comparable IFRS measure to Adjusted EBITDA is Net loss and comprehensive loss.
Adjusted EBITDA Margin
'Adjusted EBITDA Margin' means Adjusted EBITDA divided by revenue. We use Adjusted EBITDA Margin to facilitate a comparison of our operating performance on a consistent basis from period to period and to provide for a more complete understanding of factors and trends affecting our business.
(a)
Represents professional fees and other expenses paid to third parties that are incurred in connection with individual practice acquisitions and are not related to the underlying business operations of the Company.
(b)
Represents costs associated with the implementation of new corporate technology systems, the undertaking of vendor consolidations, termination benefits and restructuring activities, and professional fees related to the settlement of the management loan program and issuance of preferred shares, executive search arrangements, other non-recurring capital market initiatives and the implementation of the CDCP. Also included are costs associated with the purchase of profit rights held by Associate dentists in the cash flows of our dental practices and losses of dental practices that were disposed of during the period.
(c)
Represents the loss on disposal of dental practices that were disposed of during the reporting period.
(d)
Represents post-employment benefits provided to the Company's former President.
Expand
Adjusted Free Cash Flow
'Adjusted free cash flow' is calculated by adding or subtracting from cash flow from operating activities: (a) external acquisition expenses; (b) other corporate costs; (c) post-employment benefits; (d) short-term benefits; (e) repayment of principal on leases; (f) maintenance capital expenditure; and (g) changes in working capital. We use Adjusted free cash flow to facilitate a comparison of our operating performance on a consistent basis from period to period, to provide for a more complete understanding of factors and trends affecting our business, and to determine components of employee compensation. The most comparable IFRS measure to Adjusted free cash flow is cash flow from operating activities, for which a reconciliation is provided below.
(a)
Represents professional fees and other expenses paid to third parties that are incurred in connection with individual practice acquisitions and are not related to the underlying business operations of the Company.
(b)
Represents costs associated with the implementation of new corporate technology systems, the undertaking of vendor consolidations, termination benefits and restructuring activities, and professional fees related to the settlement of the management loan program and issuance of preferred shares, executive search arrangements, other non-recurring capital market initiatives and the implementation of the CDCP. Also included are costs associated with the purchase of profit rights held by Associate dentists in the cash flows of our dental practices and losses of dental practices that were disposed of during the period.
(c)
Represents post-employment benefits provided to the Company's former President.
(d)
Represents capital expenditures for general maintenance and safety compliance of dental practices for the reporting period.
(e)
Represents the change in non-cash working capital items for the reporting period.
Expand
Adjusted free cash flow per Share
'Adjusted free cash flow per Share' means Adjusted free cash flow divided by the total number of Shares on a fully diluted basis. Adjusted free cash flow per Share is utilized to determine components of employee compensation.
Pre-tax Adjusted Free Cash Flow
'Pre-tax Adjusted free cash flow' in respect of a period means Adjusted free cash flow less cash income tax (recovery) expense. We use Pre-tax Adjusted free cash flow to facilitate a comparison of our operating performance on a consistent basis from period to period, to provide for a more complete understanding of factors and trends affecting our business, and to determine components of employee compensation. The most comparable IFRS measure to Pre-tax Adjusted free cash flow is cash flow from operating activities.
Pre-tax Adjusted Free Cash Flow per Share
'Pre-tax Adjusted free cash flow per Share' means Pre-tax Adjusted free cash flow, divided by the total number of Shares on a fully diluted basis. Pre-tax Adjusted free cash flow per Share is utilized to determine components of employee compensation.
Adjusted Net Income
'Adjusted net income' is calculated by adding to Net loss and comprehensive loss certain expenses, costs, charges or benefits incurred in such period which in management's view are either not indicative of underlying business performance or impact the ability to assess the operating performance of our business, including: (a) amortization of intangible assets; (b) share-based compensation; (c) change in fair value of contingent consideration; (d) external acquisition expenses; (e) other corporate costs; (f) loss on disposal of dental practices; (g) change in fair value of preferred shares; (h) loss on disposal and impairment of property and equipment and intangible assets; (i) loss on settlement of other receivables; (j) impairment of right-of-use assets; (k) loss on modification of borrowings; (l) post-employment benefits; (m) short-term benefits; (n) change in fair value of other financial liability; and (o) the tax impact of the above. We use Adjusted net income to facilitate a comparison of our operating performance on a consistent basis from period to period and to provide for a more complete understanding of factors and trends affecting our business. The most comparable IFRS measure to Adjusted net income is Net loss and comprehensive loss, for which a reconciliation is provided below.
(a)
On acquisition, and at each subsequent reporting date, obligations under earn-out arrangements are measured at fair value with the changes in fair value recognized in the condensed interim consolidated statements of loss and comprehensive loss.
(b)
The Company has several De novo practices whereby the Company has issued certain put and call options over the Associate Dentists' profit rights, which have been classified as a financial liability at FVTPL. At each reporting date, changes in fair value are recognized in the condensed interim consolidated statements of loss and comprehensive loss.
(c)
At each reporting date, the Company's investment in the Management Preferred Shares, which are classified as a financial asset at FVTPL, are revalued with changes in fair value recognized in the condensed interim consolidated statements of loss and comprehensive loss.
(d)
Represents professional fees and other expenses paid to third parties that are incurred in connection with individual practice acquisitions and are not related to the underlying business operations of the Company.
(e)
Represents costs associated with the implementation of new corporate technology systems, the undertaking of vendor consolidations, termination benefits and restructuring activities, and professional fees related to the settlement of the management loan program and issuance of preferred shares, executive search arrangements, other non-recurring capital market initiatives and the implementation of the CDCP. Also included are costs associated with the purchase of profit rights held by Associate dentists in the cash flows of our dental practices and losses of dental practices that were disposed of during the period.
(f)
Represents the loss on disposal of dental practices that were disposed of during the reporting period.
(g)
Represents the loss on modification of the Company's outstanding credit facilities upon entering into an amended and restated credit agreement.
(h)
Represents post-employment benefits provided to the Company's former President.
Expand
PF Adjusted EBITDA
'PF Adjusted EBITDA' in respect of a period means Adjusted EBITDA for that period plus the Company's estimate of the additional Adjusted EBITDA that it would have recorded if it had acquired each of the dental practices that it acquired during that period on the first day of that period, calculated in accordance with the methodology described in the reconciliation table in 'Reconciliation of Non-IFRS Measures'. Both creditors and the Company use PF Adjusted EBITDA to assess our borrowing capacity, which management believes, given the highly acquisitive nature of our business, is more reflective of our operating performance. We also use PF Adjusted EBITDA to determine components of employee compensation. The most comparable IFRS measure to PF Adjusted EBITDA is Net loss and comprehensive loss.
(a)
Represents the additional Adjusted EBITDA that we estimate would have been recorded if the Company's dental practice acquisitions had occurred on the first day of the applicable reporting period. These estimates are based on the amount of Practice-Level EBITDA budgeted by us to be earned by the relevant practices at the time of their acquisition by us. There can be no assurance that if we had acquired these practices on the first day of the applicable reporting period, they would have actually generated such budgeted Practice-Level EBITDA, nor is this estimate indicative of future results.
Expand
PF Adjusted EBITDA after rent
'PF Adjusted EBITDA after rent' in respect of a period means PF Adjusted EBITDA less interest and principal repayments on leases and lease interest and principal repayments on acquisitions. Both creditors and the Company use PF Adjusted EBITDA after rent to assess our borrowing capacity, which management believes, given the highly acquisitive nature of our business, is more reflective of our operating performance. The most comparable IFRS measure to PF Adjusted EBITDA after rent is Net loss and comprehensive loss.
PF Revenue
'PF Revenue' in respect of a period means revenue for that period plus the Company's estimate of the additional revenue that it would have recorded if it had acquired each of the dental practices that it acquired during that period on the first day of that period. Given the highly acquisitive nature of our business, management believes PF Revenue is more reflective of our operating performance. We use PF Revenue to determine components of employee compensation. The most comparable IFRS measure to PF Revenue is revenue.
Net debt / PF Adjusted EBITDA after rent Ratio
'Net debt / PF Adjusted EBITDA after rent Ratio' means non-current borrowings divided by PF Adjusted EBITDA after rent. We use Net debt / PF Adjusted EBITDA after rent Ratio to assess our borrowing capacity.
Same Practice Revenue Growth
'Same Practice Revenue Growth' in respect of a period means the percentage change in revenue derived from Established Practices in that period as compared to revenue from the same dental practices in the corresponding period in the immediately prior year.
About Forward-Looking Information
This release includes forward-looking information and forward-looking statements within the meaning of applicable Canadian securities legislation, including the Securities Act (Ontario). Forward-looking information includes, but is not limited to, statements about the Company's objectives, strategies to achieve those objectives, our financial outlook, and the Company's beliefs, plans, expectations, anticipations, estimates, or intentions. Forward-looking information includes words like could, expect, may, anticipate, assume, believe, intend, estimate, plan, project, guidance, outlook, target, and similar expressions suggesting future outcomes or events.
Our forward-looking information includes, but is not limited to, the information and statements under ' First Quarter 2025 Highlights ' and 'Second Quarter 2025 Outlook' relating to our goals for the second quarter of 2025 for Revenue, Same Practice Revenue Growth, Adjusted EBITDA Margin, PF Adjusted EBITDA after rent attributable to practices acquired in 2025 and our medium-term expectations regarding Same Practice Revenue Growth and Net Debt / PF Adjusted EBITDA after rent Ratio. Such forward-looking information relating to these metrics are not projections; they are goals based on the Company's current strategies and may be considered forward-looking information under applicable securities laws and subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the control of the Company and its management.
The purpose of disclosing such forward-looking information is to provide investors with more information concerning the financial results that the Company currently believes are achievable based on the assumptions below. Readers are cautioned that the information may not be appropriate for other purposes. While these targets are based on underlying assumptions that management believes are reasonable in the circumstances, readers are cautioned that actual results may vary materially from those described above.
Forward-looking statements are necessarily based upon management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by management as of the date on which the statements are made, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in actions, events, conditions, results, performance or achievements to be different or materially different from those projected in the forward-looking statements. Forward-looking information is based on many factors and assumptions including, but not limited to, the impact of, and the enrollment of patients in, the CDCP; expectations regarding the Company's business, operations and capital structure; that the Company's acquisition program continues as it has historically, including the Company maintaining its ability to continue to make and integrate acquisitions at attractive valuations including a reduction in acquisition purchase multiples as compared to prior periods; the Company's ability to realize pricing increases, materially driven by Provincial fee guides; a continued increase in patient visit volumes through patient recall and insourcing initiatives that drive the expansion of service offerings and frequency of visits to contribute to optimal patient care; the impact of the investments the Company has made in its corporate infrastructure and teams, and the upgrades to its core information technology systems; the Company's ability to mitigate anticipated supply chain disruptions, geopolitical risks, inflationary pressures and labour shortages, and generate cash flow; no changes in the competitive environment or legal or regulatory developments affecting our business; and visits by patients to our Practices at or above the same rate as current visits.
Actual results and the timing of events may differ materially from those anticipated in the forward-looking information as a result of known and unknown risk factors, many of which are beyond the control of the Company, and could cause actual results to differ materially from the forward-looking statements. Such risks include, but are not limited to, the Company's potential inability to successfully execute its growth strategy and complete additional acquisitions; its dependence on the integration and success of its acquired dental practices; its dependence on the parties with which the Company has contractual arrangements and obligations; changes in relevant laws, governmental regulations and policy and the costs incurred in the course of complying with such changes; risks relating to the current economic environment, including the impact of any tariffs and retaliatory tariffs on the economy; risk associated with disease outbreaks; competition in the dental industry; increases in operating costs; litigation and regulatory risk; and the risk of a failure in internal controls and other factors described under 'Risk Factors' in the Company's Annual Information Form for the year ended December 31, 2024 and in this release. Accordingly, we warn readers to exercise caution when considering statements containing forward-looking information and caution them that it would be unreasonable to rely on such statements as creating legal rights regarding the Company's future results or plans. We are under no obligation (and we expressly disclaim any such obligation) to update or alter any statements containing forward-looking information or the factors or assumptions underlying them, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. All of the forward-looking information in this release is qualified by the cautionary statements herein.
About Dentalcorp
Dentalcorp is Canada's largest and one of North America's fastest growing networks of dental practices, committed to advancing the overall well-being of Canadians by delivering the best clinical outcomes and unforgettable experiences. Dentalcorp acquires leading dental practices, uniting its network in a common goal: to be Canada's most trusted healthcare network. Leveraging its industry-leading technology, know-how and scale, Dentalcorp offers professionals the unique opportunity to retain their clinical autonomy while unlocking their potential for future growth. To learn more, visit dentalcorp.ca.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

an hour ago

• Yahoo

Want to Retire Rich? 3 TSX Stocks to Add to Your Portfolio Now

Written by Sneha Nahata at The Motley Fool Canada Investing in TSX stocks with the ability to deliver above-average returns can help build wealth over time and retire rich. However, when investing for long-term financial goals, consider diversifying your portfolio to add stability and spread risk. Against this background, here are three TSX stocks that could deliver above-average returns and support you to retire rich. Dollarama (TSX:DOL) is a top TSX stock for building wealth for retirement. This Canadian dollar store retail chain consistently performs well in all market conditions, thanks to its value-focused model, and generates above-average returns. By offering everyday essentials and seasonal goods at low fixed prices, Dollarama consistently attracts strong consumer demand. Moreover, its focus on geographic expansion boosts sales and market presence. In the first quarter of fiscal 2026, Dollarama reported an 8.2% year-over-year increase in sales to $1.5 billion, with same-store sales rising 4.9%. This growth was driven by more customer visits and higher average transaction sizes. The stock has already surged 37.1% this year and has delivered nearly 315% in capital gains over the past five years by growing at an above-average compound annual growth rate (CAGR) of 32.9% Additionally, Dollarama has been consistently increasing its dividend since 2011, returning higher cash to its shareholders. Its value pricing strategy, wide product range, partnerships with third-party online delivery platforms, strong supply chain, and expanding geographical footprint will likely drive its earnings, supporting its share price and future dividend payments. 5N Plus (TSX:VNP) is a small-cap stock trading under $10. It manufactures specialty semiconductors and performance materials. These advanced components are vital to booming sectors such as renewable energy and space solar technology, positioning the company to deliver significant long-term returns. Strong demand and its focus on improving margins are enabling 5N Plus to scale profitably. Over the past five years, the stock has delivered a 486.9% return, compounding annually at 42.41%. Its bismuth-based products are gaining traction, and enhanced manufacturing capabilities combined with a robust global supply chain strengthen its outlook. Furthermore, as the demand for ultra-high-purity materials continues to increase, particularly from non-Chinese sources, 5N Plus is emerging as a crucial supplier. Its strong customer relationships, growing global presence, and leadership in niche markets make it a compelling bet for investors seeking long-term growth. Investors planning to retire rich could consider adding Cameco (TSX:CCO) to their long-term portfolios. This leading company in the nuclear energy space provides fuel, technology, and services spanning the full reactor lifecycle. Moreover, its investment in Westinghouse Electric deepens its control over the entire nuclear value chain, positioning it well to deliver reliable, carbon-free energy. With global demand for electricity surging, driven by AI-driven data centers, electrification, and decarbonization efforts, nuclear power is witnessing solid demand, and Cameco is well-positioned to capitalize on it. Thanks to solid secular demand trends, Cameco stock has increased at a CAGR of 47.5% over the past five years, delivering a return of approximately 600%. Looking ahead, its efficient production, strong market presence, and long-term supply contracts offer stability and growth potential. Cameco's expansion plans and exploration projects add further upside. Overall, Cameco's long-term outlook remains solid, making it an attractive investment for investors aiming to retire rich. The post Want to Retire Rich? 3 TSX Stocks to Add to Your Portfolio Now appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool recommends Cameco. The Motley Fool has a disclosure policy. 2025 Sign in to access your portfolio

New York Post

4 hours ago

• New York Post

Canadian tourism industry goes on offensive, as US travelers ditch Great White North

Canada's tourism industry is going on an offensive — rolling out ad campaigns in US border states to lure Americans back to the Great White North. US travel to Canada dipped by about 10% in recent months, amid the raging trade war between the two neighbors. An American tourist looks confused as he receives a warm hug from a Canadian hotel employee in a new TV ad. YouTube/Tourisme Cantons-de-l'Est Advertisement In one TV ad running across New England and New York, an American tourist – sporting a baseball cap and matching sweater tied around his shoulders – sheepishly whispers to a Canadian hotel front desk worker that he's from the land of the free. The employee looks awkwardly towards him and presses what looks like some kind of red panic button – before bursting out a smile and walking across the desk to hug him. Advertisement Other ads take more of a practical approach, trying instead to appeal to American's pocketbooks. One billboard campaign simply reminds Americans how much further their dollar will go north of the 49th parallel. '$1 USD = $1.43 CAD,' reads the billboard from Destination Ontario, which has been spotted in Detroit and Cleveland, among other border towns. 'Spend less, do more.' Americans make up more than three-quarters of tourists to Canada. Destination Ontario Advertisement American tourists make up the bulk of visitors to Canada – last summer, 78.5%, nearly four out of five visitors to the Great White North came from the US. The drop hasn't been as dramatic as Canadian tourists to the US – who've boycotted the country en masse, leading to a 30-40% fall in air and land travel. But it's sure to make a dent in the tourism industry – according to Statistics Canada, Americans spent $15.3 billion in the country last year.

Business Upturn

12 hours ago

• Business Upturn

LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025

By GlobeNewswire Published on June 21, 2025, 02:30 IST LEADING EDGE MATERIALS REPORTS QUARTERLY RESULTS TO APRIL 30, 2025 Vancouver, June 20, 2025 – Leading Edge Materials Corp. ('Leading Edge Materials' or the 'Company') (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) announces results for the fiscal period ending April 30, 2025. All references to dollar amounts in this release are in Canadian dollars. Highlights During and After the Quarter During the three months ended April 30, 2025: • On February 9, 2025, the Company provided an update on a Rapid Development Plan ('RDP') for Norra Kärr, to be in production in the shortest possible timeframe, supplying HREE-rich eudialyte concentrate and industrial mineral nepheline syenite. • The Company provided an update on the value creation options being considered for Woxna Graphite, on February 16, 2025, including a possible restart of operations, the production of high-quality flake graphite concentrate. • On March 23, 2025, the Company provided a progress update on Norra Kärr, in the context of the European Commission's ('EC') Joint White Paper for European Readiness 2030, highlighting the increasing geopolitical competition over critical raw materials ('CRMs') and the need for the EU and its member states to build strategic reserves of raw materials. • On March 25, 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act ('CRMA'); Norra Kärr was not included. The Company stated its plan to reapply in the next round of applications. • On April 23, 2025, the Company announced granting of stock options (the 'Options') to directors, officers and consultants of the Company to purchase an aggregate of 6,850,000 common shares (the 'Optioned Shares') of the Company, at exercise price of C$0.24 per Optioned Share, expiring on the date that is 5 years from the date of grant for directors and officers and three years from the date of grant for consultants. The Options will vest 33% on the date of the grant, 33% one year after the date of grant and 34% two years after the date of grant. The Options were issued pursuant to the terms of the Company's Option Plan. Results of Operations Three Months Ended April 30, 2025, Compared to Three Months Ended January 31, 2025 During the three months ended April 30, 2025 ('Q2 2025') the Company reported a net loss of $1,179,168 compared to a reported net loss of $669,216 for the three months ended January 31, 2025 ('Q1 2025'), an increase in loss by $509,952, the increase in loss mainly due to share based compensation expenses of $585,529 (Q1 2025 – $129,292) and foreign exchange loss of $117,063 (Q1 2025 – gain $1,690). Three Months Ended April 30, 2025, Compared to Three Months Ended April 30, 2024 During the three months ended April 30, 2025 ('2025 period'), the Company reported a net loss of $1,179,168 compared to a net loss of $859,529 for the three months ended April 30, 2024 ('2024 period'), an increase in loss of $319,639, the increase in loss mainly due to share based compensation expenses of $585,529 (Q2 2024 – $349,923) and foreign exchange loss of $117,063 (Q2 2024 – $5,754). Selected Financial Data The following selected financial information is derived from the unaudited condensed consolidated interim financial statements of the Company prepared in accordance with IFRS. Fiscal 2025 Fiscal 2024 Fiscal 2023 Three Months Ended April 30,2025 $ January 31,2025 $ October 31,2024 $ July 31,2024 $ April 30,2024 $ January 31,2024 $ October 31,2023(Restated) $ July 31,2023(Restated) $ Operations Expenses (1,070,402) (696,037) (97,209) (797,070) (863,745) (660,617) (457,890) (309,832) Other items (108,766) 26,821 (222,820) (25,168) 4,216 (25,311) 195,209 (8,442) Comprehensive profit/(loss) (1,179,168) (669,216) (320,029) (822,238) (859,529) (685,928) (262,681) (318,274) Basic Profit/(loss) per share (0.01) (0.00) (0.00) (0.00) (0.01) (0.00) (0.00) (0.00) Diluted profit/(loss) per share (0.01) (0.00) (0.00) (0.00) (0.01) (0.00) (0.00) (0.00) Financial Position Working capital 1,191,514 2,198,641 3,337,686 3,973,458 1,610,635 2,316,098 2,713,098 848,952 Total assets 28,361,774 28,480,311 29,343,716 28,454,783 24,991,481 26,003,943 25,512,111 23,588,662 Total non-current liabilities (6,009,933) (5,596,369) (5,641,854) (5,683,545) (5,101,289) (5,489,843) (4,670,790) (5,109,575) Financial Condition / Capital Resources During the three months ended April 30, 2025, the Company recorded a net loss of $1,179,168 and, as of April 30, 2025, the Company had an accumulated deficit of $51,201,042 and working capital of $1,191,514. The Company maintains its Woxna Graphite mine in a 'production-ready' basis while minimizing costs. The Company is also evaluating a potential restart of flake graphite concentrate production. The Company anticipates that it has sufficient funding to meet anticipated levels of corporate administration and overheads for the ensuing twelve months however, it will need additional capital to provide working capital and recommence operations at the Woxna Graphite, to fund future development of the Norra Kärr project or to complete exploration activities in Romania. There is no assurance such additional capital will be available to the Company on acceptable terms or at all. In the longer term the recoverability of the carrying value of the Company's long-lived assets is dependent upon the Company's ability to preserve its interest in the underlying mineral property interests, the discovery of economically recoverable reserves, the achievement of profitable operations and the ability of the Company to obtain financing to support its ongoing exploration programs and mining operations. Outlook Concerns about critical raw materials – security of supply, supply chain resilience and defence requirements – have been recurring themes at conferences attended by the Company in recent months, with HREEs and natural graphite frequently mentioned; geopolitical uncertainties continue, with more talk about the weaponization of global trade in rare earth elements. On June 17, 2025, the G7 Critical Minerals Action Plan was announced focused on 'diversifying the responsible production and supply of critical minerals, encouraging investments in critical mineral projects and local value creation, and promoting innovation' in the G7, and with partners beyond, working together and 'to swiftly protect our economic and national security''. Against this backdrop and calls for more action to match the intent of the CRMA, the Company's portfolio is well positioned. Woxna Graphite Mine The Company maintains the Woxna Graphite Mine in a production-ready state while minimizing holding costs. An internal study completed in early 2022 assessed the potential for restarting operations and upgrading the processing plant to produce high-quality flake graphite concentrate. Work is now underway to update this study, forming the basis of a business plan to support possible project financing, customer prepayments, and access to Swedish or EU public funding, and, in addition. Highlighting Sweden's role in CRMs and graphite's importance, Sweden's Energy, Business and Industry Minister Ebba Busch recently stated that 'Sweden has unique opportunities to be and remain a strong player in global mineral politics. We have the most sustainable mining industry in the world – ethically sustainable, environmentally sustainable, and with good working conditions. The graphite that [Talga Group] is planning to produce is a key material in battery manufacturing and the green transition to a fossil-fuel-free society.' Norra Kärr Heavy Rare Earth Element ('HREE') Project As part of its Pre-feasibility ('PFS') workstreams, the Company is developing a Rapid Development Plan ('RDP') for Norra Kärr to enable the earliest possible production of HREE-rich eudialyte concentrate and industrial mineral nepheline syenite. A phased, small-scale start is under consideration to allow early access to the deposit, initial sales of nepheline syenite, early cash flow, and stockpiling of eudialyte concentrate for future processing. This approach is designed to reduce both risk and environmental impacts. Testwork has now been completed on nepheline syenite and aegirine to determine their mineralogy, chemical composition, and leachate chemistry. The promising results are being used to determine possible market segments and specifications that can be achieved, potential demand and pricing, to be included in an updated PFS economic model for Norra Kärr. The Company envisages the PFS will be completed in Q1 2026. On 24 March 2025, the EU announced its first list of Strategic Projects under the Critical Raw Materials Act (CRMA); Norra Kärr was not included. The Company plans to reapply in the next round of applications having continued to make significant progress since the last application was submitted in August 2024. In recent months, the Company's application for a new Exploitation Concession ('Bearbetningskoncession') 25-year mining lease has been out for consultation with County Administrative Boards ('CAB') and municipalities. The Company understands that CAB opinions have been received by the Mining Inspectorate ('Bergsstaten'). The Company will have an opportunity to respond to opinions and comments. Bihor Sud Nickel-Cobalt Exploration Project Exploration activities at the Bihor Sud project have continued, supported by the hard work of the four new geologists who joined the team in January. Works have included underground mapping, diamond drilling, geophysics, core logging, and sampling. The Company's goal remains to define a large-scale, mineable mineral resource; in gallery G2, targeting promising Zinc-Lead-Copper-Silver mineralization. Results to date are encouraging and underscore the project's strong potential for a significant polymetallic discovery. Financial Information The report for three months ending July 31, 2025, is expected to be published on or about September 19, 2025. On behalf of the Board of Directors, Leading Edge Materials Corp. Kurt Budge, CEO For further information, please contact the Company at: [email protected] Follow usTwitter: Linkedin: About Leading Edge Materials Leading Edge Materials is a Canadian public company focused on developing a portfolio of critical raw material projects located in the European Union. Critical raw materials are determined as such by the European Union based on their economic importance and supply risk. They are directly linked to high growth technologies such as lithium-ion batteries and permanent magnets for electric motors, wind turbines and defense applications. The portfolio of projects includes the 100% owned Woxna Graphite mine (Sweden), 100% owned Norra Kärr Heavy Rare Earth Elements project (Sweden), and the 51% owned Bihor Sud Nickel Cobalt exploration alliance (Romania). Additional Information The information was submitted for publication through the agency of the contact person set out above, on June 20, 2025, at 2:30 PM Vancouver time. Leading Edge Materials is listed on the TSXV under the symbol 'LEM', OTCQB under the symbol 'LEMIF' and Nasdaq First North Stockholm under the symbol 'LEMSE'. Svensk Kapitalmarknadsgranskning ('SKMG') is the Company's Certified Adviser for the Nasdaq First North Growth Market (Stockholm) and may be contacted via email [email protected] or by phone +46 (0)8 913 008. Reader Advisory This news release may contain statements which constitute 'forward-looking information', including statements regarding the plans, intentions, beliefs and current expectations of the Company, its directors, or its officers with respect to the future business activities of the Company. The words 'may', 'would', 'could', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' and similar expressions, as they relate to the Company, or its management, are intended to identify such forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future business activities and involve risks and uncertainties, and that the Company's future business activities may differ materially from those in the forward-looking statements as a result of various factors, including, but not limited to, fluctuations in market prices, changes in the Company's intended use of proceeds from the Private Placement, successes of the operations of the Company, continued availability of capital and financing and general economic, market or business conditions. There can be no assurances that such information will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. The Company does not assume any obligation to update any forward-looking information except as required under the applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release. Attachments LEM – News Release Financial Results – April 30, 2025 Financial Report Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.